First Premier Bank Abb Vie Inc. Transaction History

First Premier Bank

$401 Million
Q3 2024

A detailed history of First Premier Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, First Premier Bank holds 7,426 shares of ABBV stock, worth $1.33 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

7,426

Previous 7,220 2.85%

Holding current value

$1.33 Million

Previous $1.24 Million 18.42%

% of portfolio

0.37%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$163.84 - $199.33 $33,751 - $41,061	206 Added 2.85%	7,426 $1.47 Million
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $9,589 - $10,926	60 Added 0.84%	7,220 $1.32 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $34,400 - $38,742	-250 Reduced 3.37%	7,160 $1.11 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $77,482 - $89,697	-580 Reduced 7.26%	7,410 $1.1 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $272,573 - $339,199	-2,057 Reduced 20.47%	7,990 $1.08 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $33,404 - $38,470	231 Added 2.35%	10,047 $1.6 Million
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $58,090 - $69,665	420 Added 4.47%	9,816 $1.59 Million
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $5,368 - $6,157	-40 Reduced 0.42%	9,396 $1.26 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $17,202 - $21,870	-125 Reduced 1.31%	9,436 $1.44 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $36,690 - $45,522	278 Added 2.99%	9,561 $1.55 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $966 - $1,223	9 Added 0.1%	9,283 $1.26 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $12,236 - $13,889	115 Added 1.26%	9,274 $1 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $29,984 - $33,404	285 Added 3.21%	9,159 $1.03 Million
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $66,495 - $73,203	650 Added 7.9%	8,874 $960,000
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $134,901 - $182,130	1,676 Added 25.6%	8,224 $882,000
Q2 2020 Jul 07, 2020	SELL	$73.37 - $98.18 $3,668 - $4,909	-50 Reduced 0.76%	6,548 $642,000
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $5,482 - $8,312	85 Added 1.31%	6,598 $502,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $124,063 - $155,230	-1,720 Reduced 20.89%	6,513 $577,000
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $43,456 - $52,246	690 Added 9.15%	8,233 $623,000
Q2 2019 Jul 09, 2019	BUY	$65.7 - $83.98 $19,710 - $25,194	300 Added 4.14%	7,543 $549,000
Q1 2019 Apr 04, 2019	BUY	$77.14 - $90.79 $174,722 - $205,639	2,265 Added 45.5%	7,243 $583,000
Q4 2018 Jan 14, 2019	BUY	$77.85 - $96.01 $19,306 - $23,810	248 Added 5.24%	4,978 $459,000
Q3 2018 Oct 09, 2018	BUY	$88.91 - $98.84 $86,687 - $96,369	975 Added 25.97%	4,730 $447,000
Q1 2018 Apr 09, 2018	SELL	$92.01 - $123.21 $41,404 - $55,444	-450 Reduced 10.7%	3,755 $355,000
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $42,093 - $46,158	-470 Reduced 10.05%	4,205 $407,000
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $326,548 - $417,103	4,675	4,675 $415,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.

Account

First Premier Bank Abb Vie Inc. Transaction History